Shlipak, Michael G.
UCSF School of Medicine,
United States
2025 Rank: 11017
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 57 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11017 | 10397 |
| Total Cites | 5215 | 5853 |
| H-index | 23 | 25 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 390 | 422 |
| Number of Single+First+Last Authored Papers | 222 | 222 |
| Total Cites to Single+First+Last Authored Papers | 863 | 971 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3976 | 4216 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.39 |
| Self-Citation Percentage |
10.90%
|
|
Shlipak, Michael G.
University of California, San Francisco,
United States
2024 Rank: 19871
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 111 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19871 | 20057 |
| Total Cites | 2608 | 2796 |
| H-index | 19 | 20 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 258 | 270 |
| Number of Single+First+Last Authored Papers | 189 | 189 |
| Total Cites to Single+First+Last Authored Papers | 656 | 716 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2076 | 2161 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
6.72%
|
|
Shlipak, Michael G.
San Francisco VA Health Care System,
United States
2023 Rank: 15417
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 95 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15417 | 16551 |
| Total Cites | 3015 | 3228 |
| H-index | 21 | 21 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 253 | 264 |
| Number of Single+First+Last Authored Papers | 189 | 189 |
| Total Cites to Single+First+Last Authored Papers | 745 | 784 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2402 | 2495 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
6.60%
|
|
Shlipak, Michael G.
University of California, San Francisco,
United States
2022 Rank: 16885
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 108 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16885 | 16946 |
| Total Cites | 3331 | 3754 |
| H-index | 23 | 24 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 260 | 269 |
| Number of Single+First+Last Authored Papers | 189 | 189 |
| Total Cites to Single+First+Last Authored Papers | 741 | 799 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2662 | 2876 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.31 |
| Self-Citation Percentage |
11.27%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.